Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | phosphotransferase enzyme family protein | 0.0333 | 1 | 0.5 |
Echinococcus multilocularis | choline:ethanolamine kinase | 0.0333 | 1 | 1 |
Plasmodium falciparum | choline kinase | 0.0333 | 1 | 0.5 |
Plasmodium vivax | choline kinase, putative | 0.0333 | 1 | 0.5 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0132 | 0 | 0.5 |
Echinococcus granulosus | choline:ethanolamine kinase | 0.0333 | 1 | 1 |
Loa Loa (eye worm) | choline/ethanolamine kinase | 0.0333 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | Antifungal activity against Cryptococcus neoformans ATCC 32264 by agar dilution method | ChEMBL. | 10543891 | |
Activity (functional) | Antifungal activity against Candida albicans ATCC 10231 by agar dilution method | ChEMBL. | 10543891 | |
Activity (functional) | Antifungal activity against Saccharomyces cerevisiae ATCC 9763 by agar dilution method | ChEMBL. | 10543891 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.